ProKidney Corp.

Biotech

ProKidney Corp. Skyrockets 515% on Trial Data, But is it a Buy?

July 8, 2025
0
Human kidney surrounded by a glowing light.

Shares of ProKidney Corp. (NASDAQ: PROK) soared 515% on Tuesday, triggering shockwaves across Wall Street after the company unveiled highly…

Read More »
Back to top button